Roivant Sciences raised €178M in a funding round in Nov 2018. The company is based in Basel, Switzerland. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
